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Abstract 
Postoperative pain is an unpleasant consequence of all surgical procedures.  It is an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage.  There are many negative consequences to postoperative pain including delayed 
recovery, increased healthcare costs, and overall dissatisfaction with care.  There are 
many methods to minimize postoperative pain.  Spinal anesthesia has been used for years 
to improve postoperative pain across a variety of surgical procedures.  New research has 
shown that the use of adjuvant medications with intrathecal bupivacaine greatly improves 
postoperative pain.  One adjuvant medication is dexmedetomidine.  The purpose of this 
systematic review was to determine if the administration of intrathecal dexmedetomidine, 
as an adjuvant medication to bupivacaine, impacts postoperative pain in adult patients 
undergoing surgery.  A literature review was conducted using the PRISMA flow diagram.  
Data was then collected from each study and a cross study analysis was conducted.  
Findings indicated, in all studies, the addition of dexmedetomidine to intrathecal 
bupivacaine decreased postoperative pain levels.  Integration of dexmedetomidine into 
spinal anesthesia can make an immense difference in postoperative analgesia and 
recovery, an important consideration for anesthesia providers. 
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The Impact of Intrathecal Dexmedetomidine as an Adjuvant to Bupivacaine on 
Postoperative Pain  
Background/Statement of the Problem 
Postoperative analgesia is a substantial and current issue in the healthcare field 
today.  Unfortunately, postoperative pain is inadequately managed in greater than 80% of 
patients in the United States (U.S.) (Gan, 2017).  Patients that undergo surgical 
procedures can suffer from harsh complications following the procedure.  Even when 
surgery is successful, patients suffer from pain postoperatively.  
 The number of surgeries being performed is at an all-time high and will continue 
to increase as advances in medical technology allow surgeons to perform procedures they 
never have before.  Despite improved understanding of pain mechanisms, increased 
awareness of the prevalence of postsurgical pain, advances in pain-management 
approaches and inadequately controlled postoperative pain continues to be a problem 
(Gan, 2017). 
 Postoperative pain is associated with many negative outcomes, both for the 
patient and the hospital.  The patient will suffer from prolonged recovery, immobility, 
increased morbidity, and overall dissatisfaction with care (Gan, 2017).  Both the patient 
and the hospital will experience increased medical costs due to increased medication use 
and a prolonged hospital stay.  More importantly, poorly managed acute pain can result in 
the development of chronic pain (Gan, 2017).  
 Many interventions are available for treating acute postoperative analgesia but 
may fall short of fully eradicating it.  A favorable management strategy for postoperative 
pain is to address it pre-emptively, instead of waiting until the post-operative period.  
Intra-operatively the anesthesia provider can administer a variety of medications that will 
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greatly improve analgesia following surgery.  One method is to use local anesthetics and 
possible adjuvants to local anesthetics, such as dexmedetomidine.  Garimella and Cellini 
(2013) stated that intrathecal administration of a local anesthetic (0.5% bupivacaine) at 
induction of anesthesia results in good postoperative analgesia for up to 24 hours.  If an 
adjuvant medication were to be added to the bupivacaine, that time could be even longer.  
The use of adjuvant medications with local anesthetics to help improve 
postoperative analgesia is a new intervention that is still being researched.  Some 
medications being used as adjuvants are dexamethasone, clonidine, and 
dexmedetomidine.  The benefit of these medications towards postoperative analgesia 
needs to be considered, along with other effects they might pose.  Overall, it is believed 
the administration of these medications with local anesthetics will improve postoperative 
analgesia.  This is an important consideration for anesthesia providers, as it could make 
an immense difference in postoperative analgesia and recovery. 
Effectively treating pain leads to patient comfort, which allows for fewer 
complications, early mobility, and early discharge.  These positive outcomes not only 
benefit the patient, but the hospital as well.  Fewer complications and early discharge 
result in decreased health costs for the facility.  With thousands of surgeries being 
performed daily, the need for controlled postoperative analgesia is essential.  
Therefore, the purpose of this paper is to complete a systematic review to 
determine if the administration of intrathecal dexmedetomidine, as an adjuvant 
medication to bupivacaine, impacts postoperative pain in adult patients undergoing 
surgery.  
Next, the review of literature will be presented. 
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Literature Review 
 
A literature review was conducted using the databases CINAHL, Medline, and 
PubMed.  A combination of search terms were used to gather the appropriate research 
articles.  Those search terms were: adjuvant, postoperative pain, local anesthesia, 
dexmedetomidine, dexamethasone, and clonidine.  The search was limited to peer 
reviewed articles and written in the English Language.  There was no limit entered for 
year published, but all the articles chosen were published between 2007-2018.   
Definition and Pathophysiology of Pain 
The International Association for the Study of Pain (IASP) defines pain as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage” (Merksey, H., & Bogduk, N., 2012).  
There are many different categories of pain, but for this review the focus is on 
nociceptive pain.  When there is damage to tissues, the body transmits a signal to the 
brain.  It does so by a process termed nociception, which is defined as the neural process 
of encoding and transducing the noxious stimuli received by the body (Dubin & 
Patapoutian, 2010).  The presence of peripheral sensory neurons throughout the body 
allows this process to occur.  These specialized neurons are called nociceptors.  
Nociceptors are found in the skin, bone, muscle, and joints.  They are activated by 
chemicals, such as Substance P or Glutamate, and are released when there is tissue 
damage.  This is the first phase of the pain pathway and is referred to as transduction.  
The chemicals that are released excite the nociceptors, producing an action potential. 
Dubin and Patapoutian (2010) defined action potential as an electric signal that is 
propagated along nerves, enabling communication between neurons within the pain 
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pathway.  This electric signal travels to the dorsal horn of the spinal cord where it 
synapses with secondary neurons and then travels to the thalamus within the brain.  This 
is the second phase of the pain pathway and is called transmission.  Next, the process of 
perception allows the body to become conscious of the noxious stimuli and allows 
modulation of pain to take place.  Modulation involves facilitatory and inhibitory 
pathways in the spinal cord (Dubin & Patapoutian, 2010).  This causes the release of 
neurotransmitters that aim to inhibit nociception to free the body of pain, completing the 
pain pathway.    
In a descriptive study conducted by Rodriguez (2015), it is stated that pain elicits 
protective reflexes such as an unconscious withdrawal from the noxious stimulus, muscle 
spasms, and other autonomic reactions.  This response occurs following the perception 
and modulation of a pain signal.  For example, if you were to burn your finger while 
cooking dinner, the second your finger touched the hot pan nociceptors would respond to 
the temperature and relay a signal through the neuronal axon up to the spinal cord, and 
then to the brain causing you to withdraw your hand from the source of pain.  
Pain is an ongoing problem that is dominating society.  While there are many 
causes of pain, acute postoperative pain is an evident issue existing in healthcare today. 
Much research has been conducted on interventions to reduce postoperative pain but 
postoperative pain is not adequately managed in greater than 80% of patients in the U.S. 
(Gan, 2017).  
Postoperative Pain    
 Management of postoperative pain is essential in the surgical patient.  Pain causes 
discomfort, which leads to many postoperative complications including pneumonia, 
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mobility issues, constipation, and prolonged rehabilitation.  Pain also increases the stress 
response of the immune system, causing difficulties with healing (Banks, 2007).  There 
are many interventions used to treat postoperative pain.  These interventions are key in 
facilitating positive patient outcomes following surgical procedures.  While there is no 
defined best method of treating pain, heath care providers must consider that under 
treatment of postoperative pain results in many negative effects, and it is crucial to be 
informed of all current interventions to treat postoperative pain (Banks, 2007). 
 Recent evidence determined that 80% of patients who underwent surgical 
procedures experienced acute postoperative pain, and less than half reported adequate 
pain relief (Chou et al., 2016).  This is an astounding statistic that led to the development 
of new guidelines regarding management of postoperative pain control.  In 2016, The 
American Pain Society published 32 recommendations to promote effective management 
of postoperative pain (Chou et al).  These recommendations range from generalized to 
specific. Within the new guidelines, the use of local anesthetics is highly recommended.  
Chou et al. (2016) stated that local anesthetics have been shown to be effective as a 
component of multi-modal analgesia for management of postoperative pain associated 
with many surgical procedures; however, prior to treating pain, it must be understood 
how to measure it. 
Measuring Postoperative Pain.  Earlier, this review addressed the 
pathophysiology of pain, including perception of pain.  As stated before, it is when the 
brain interprets and processes a pain signal.  This is a subjective phenomenon that can 
vary between individuals.  A surgery that causes considerable pain for one person could 
cause no pain at all for someone else due to the processing of pain signals in the brain.  
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This poses a problem; how do we measure pain if it is perceived differently in each 
patient?  The subjective nature of pain makes its reliable measurement by health 
professionals a key factor in its successful management (Coll, Ameen, & Mead, 2004).  A 
thorough nurse assessment coupled with pain measurement scales is the current standard 
for addressing postoperative pain. 
There are a multitude of scales available to assist with measuring postoperative 
pain.  Among the most commonly used are the Visual Analog Scale (VAS) and the 
Numerical Rating Scale (NRS).  It is important to understand how these scales work to 
adequately interpret research results regarding postoperative pain.  While both scales 
focus on the patient’s perception of pain, they do so in different manners. 
The VAS consists of a 100-millimeter line, usually horizontal, with the ends of 
the lines representing extremes of pain interpretation.  The left side represents ‘no pain’ 
and the opposite end represents ‘unbearable pain’ (Coll et al., 2004).  The patient is asked 
to point or make a mark on the line where their pain level falls.  That point is then 
measured how far away from the left (lower) side of the line it is in millimeters.  The 
larger the distance the more intense the pain.  Once the distance is determined, the pain 
can be treated appropriately.   
The NRS measures pain similarly.  Its original form consisted of a horizontal line, 
in which one end is labeled 0 and the other end labeled 10; the patient is asked to pick a 
point along the line, from 0-10, to identify the intensity of their pain (Coll et al., 2004).  
Since its original development different versions of this scale have been produced but the 
generality of rating pain from 0-10 is one of the most commonly used approaches today 
(Coll et al., 2004).   
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Validity of the VAS and NRS.  Valid and reliable pain assessment tools are 
essential in the management and treatment of postoperative pain.  Medical professionals 
use pain scales to guide treatment plans.  If the scales are unreliable, the treatment plan 
will be inadequate.  Studies have been conducted to assess validity and reliability of the 
different pain scales.  A systematic review by Hjermstad et al. (2011) examined the use 
and performance of unidimensional pain scales, including the VAS and the NRS, in 
cancer patients.  Hjermstad et al. (2011) found that both the VAS and NRS work well, 
and the most important choice is not the type of scale, but the conditions related to its 
use.  It is necessary to choose the scale based on the patient’s level of cognitive 
functioning.  Although the VAS was the most frequently used pain scale, it was found 
that the NRS suited some patients better.  For example, Hjermstad et al. (2011) reported 
that the NRS was superior in 11 studies due to ease of use and high compliance, while 
lower compliance was found with the VAS in patients associated with higher age, degree 
of trauma, or other impairments.  Thus, it can be assumed the scale is better utilized when 
patient specific factors are considered, but the subjectivity of pain makes it necessary to 
assess pain perception in a standardized fashion.  Hjermstad et al. (2011) found that both 
the NRS and the VAS work well in comparison, so either tool is acceptable.   
Once a measurement technique is determined, the provider can determine what 
the best plan for treatment is.  There are many approaches to treating postoperative pain, 
but this review will focus on local anesthetics. 
Local Anesthetics and Their Role in Pain Control 
 Local anesthetics contain a group of medications that work by inhibiting sensory, 
motor, and autonomic nerve function (Butterworth, Mackey, & Wasnick, 2013).  These 
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are medications classified as esters or amides that block nerve function, using the nerve 
roots as the site of action.  Normally, activation of sodium channels causes an influx of 
sodium ions, generating an action potential (Butterworth et al., 2013).  Local anesthetics 
diffuse into the cell where they bind to sodium channels, blocking them.  This prevents 
depolarization, which inhibits any action potentials from being spread.  By preventing the 
action potential, sensation in that area is decreased or completely hindered.  Local 
anesthetics are commonly used alone in surgical procedures but can be combined with 
other medications to improve analgesic outcomes.  The main local anesthetics used in 
practice today are bupivacaine, ropivacaine, levobupivacaine, and hyperbaric 
bupivacaine.  
Bupivacaine.  Bupivacaine is the preferred local anesthetic in caudal, epidural, 
and spinal anesthesia and is used to manage acute and chronic pain (Paganelli & Popescu, 
2015).  In addition to blocking sodium channels intracellularly, bupivacaine has been 
thought to have inhibitory effects on the N-Methyl-D-aspartic acid (NMDA) receptor.  
Inhibition of the NMDA receptor is an effective strategy in prevention and management 
of chronic pain syndromes (Paganelli & Popescu, 2015).  
 Bupivacaine is considered a long acting local anesthetic with a duration time of 
four to eight hours (Paganelli & Popescu, 2015).  Bupivacaine is also known for its high 
level of sensory anesthesia and can be administered locally in the skin or regionally into 
the spine, which is referred to as intrathecal administration.  Intrathecal administration 
consists of injecting the medication directly into the spinal column and into the 
cerebrospinal fluid.  Injecting the medication into the spine allows for regional 
anesthesia, which blocks sensation in an area of the body.  
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Adjuvants to Local Anesthetics to Improve Postoperative Pain 
 The use of adjuvants with local anesthetics has been practiced for several years 
now but continues to be a relevant subject of interest (Wiles & Nathanson, 2010).  While 
local anesthetics have satisfactory effects, there continues to be an ongoing search for 
medications with longer duration of action, better nerve selectivity, less degree of motor 
block, and a lower occurrence of systemic toxicity (Wiles & Nathanson, 2010).  The use 
of adjuvant medications along with local anesthetics aims to provide these outcomes. 
With the ability to prolong local anesthetic blockade, specifically sensory block, there 
would be a drastic decrease in postoperative pain levels.  There are several medications 
that have been trialed for adjuvants to local anesthetics including clonidine and 
dexamethasone.  These medications will be discussed briefly in this literature review, but 
the focus is on dexmedetomidine as an adjuvant and will be discussed in more depth.  
Clonidine as an adjuvant to local anesthetic.  Clonidine is a selective 2 
adrenergic agonist and works by decreasing peripheral vascular resistance.  As a result 
blood vessels relax, allowing decreased blood pressure and heart rate.  A prospective, 
randomized, controlled trial (RCT) by Chakraborty, Chakrabarti, Mandal, Hazra, and Das 
(2010), compared the effect of low dose clonidine versus placebo as an adjuvant to 
bupivacaine.  Quantitative data was collected through an experimental, double blinded 
study approach.  The sample included 70 participants, ages 18-60, and participants were 
randomly allocated into one of two groups.  Group A received bupivacaine with 
clonidine, while Group B received bupivacaine with normal saline.  Chakraborty et al. 
(2010) found a significant difference of approximately 221 minutes from the time group 
A needed analgesia medication to the time Group B needed to be medicated (p < 0.001).  
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This study suggested that low dose clonidine as an adjuvant to bupivacaine prolonged the 
duration of analgesia.  
 Gorniak, Proost, Veckeneer, Mulder, and Wubbels, (2014) conducted a 
prospective RCT, which aimed to determine the effect of clonidine as an adjuvant to 
levobupivacaine on postoperative analgesia.  The study included 120 participants 
randomly assigned to two groups.  Group one received only levobupivacaine while group 
two received levobupivacaine with clonidine.  Data was collected by a patient self-
reported questionnaire, and only 101 participants completed and returned the 
questionnaire.  The participants were asked to rate post-operative pain using the VAS 
ranging from 0-10, and 10 being the worst pain imaginable (Gorniak et al., 2014).  
Gorniak et al. (2014) found that the use of clonidine as an adjuvant to local anesthesia is 
limited in terms of benefits and reducing post-op pain.  Participants who reported pain 
compared to those who did not report pain in the control group were 18:34, and 18:31 in 
the clonidine group.  Hence, there was not a significant difference between the two 
groups.  
 Dexamethasone as an adjuvant to local anesthetics.  Dexamethasone is a 
corticosteroid; a class of medications that aid primarily in reducing inflammation.  
Desmet et al. (2013) conducted a prospective, randomized, placebo-controlled study in 
which researchers hypothesized that intravenous (IV) and perineural (around nerves) 
dexamethasone have an equal effect of prolonging analgesia when used with the local 
anesthetic nerve block ropivacaine.  A sample size of 150 participants was allocated 
randomly into one of three groups.  Group one received ropivacaine only, group two 
received ropivacaine with perineural dexamethasone 10 mg, and group three received IV 
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dexamethasone 10 mg only.  Data was collected by the NRS, on a scale of 0-4 with 4 
being severe pain.  Researchers found dexamethasone significantly prolonged the 
duration of analgesia (p < 0.001).  The results strongly supported the researcher’s 
hypothesis. 
  Desmet et al. (2015) conducted a second RCT in which dexamethasone was 
combined with a local anesthetic for shoulder surgery.  The researchers hypothesized that 
different doses of dexamethasone would prolong analgesic duration of the local 
anesthetic block.  The study was a prospective, placebo-controlled, randomized trial that 
allocated 240 participants into four separate groups, 60 in each group.  Participants either 
received IV saline 0.9%, or a dose of dexamethasone 1.25mg, 2.5mg, or 10mg during 
surgery.  All were adjuvants to the local anesthetic ropivacaine.  Data was collected by 
patient self-report, and participants would rate their pain as none, mild, moderate, or 
severe.  Researchers found that IV dexamethasone prolongs the duration of postoperative 
analgesia with a greater effect at a dose of 10mg than 2.5mg (Desmet et al., 2015).  No 
statistical difference was noted between dexamethasone doses of 2.5mg versus 10mg.  
Generally, when dexamethasone was used with ropivacaine analgesia was prolonged, as 
opposed to when ropivacaine was used with normal saline.  The results supported the 
researcher’s hypothesis. 
Dexmedetomidine as an Adjuvant to Local Anesthetics.  Dexmedetomidine is 
a selective alpha-2 agonist approved for sedation but has more recently been investigated 
for its analgesic effects.  It has an effect on the body both peripherally and centrally.  
Peripherally, it decreases the release of norepinephrine causing inhibition of nerve action 
potentials (Nazir & Jain, 2016).  Centrally, it causes inhibition of the release of substance 
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P at the level of the dorsal root neuron resulting in analgesia (Nazir & Jain, 2016).  More 
specifically, it has been used intrathecally as an adjuvant to spinal anesthesia to assist in 
prolonging efficacy of both medications (Das et al., 2015).  
 Das et al. (2015) conducted a prospective, double blind, randomized controlled 
study and compared two different doses of dexmedetomidine added to bupivacaine on 
duration of analgesia.  The sample consisted of 100 participants scheduled to have an 
abdominal hysterectomy under spinal anesthesia.  The participants were allocated using a 
computer-generated random number list into two different groups.  Participants either 
received 5 mcg or 10 mcg of dexmedetomidine.  Both doses of dexmedetomidine were 
administered along with 15mg of bupivacaine.  The anesthetic technique was 
standardized for each participant, and the intervention was applied exactly as stated, 
assuring intervention fidelity.  Data was collected postoperatively by patients’ self-report 
of pain based on the VAS.  After analyzing the data, researchers found that spinal 
dexmedetomidine increased the time before first analgesic use was required, and it also 
decreased analgesic consumption.  The group that received the 10 mcg waited longer 
before taking the first dose of analgesic medications than the group that received only  
5 mcg (P<0.05), and also required less breakthrough pain medication overall (Das et al., 
2015).  The evidence supported the author’s hypothesis. 
  A study was conducted by Nazir and Jain (2016) that aimed to compare the 
postoperative analgesic effects of dexmedetomidine for brachial plexus blockade along 
with bupivacaine.  A brachial plexus blockade is when a local anesthetic is injected 
during surgery on the upper extremity.  This was a prospective, randomized, controlled 
trial that consisted of 70 participants.  Participants were allocated into two separate 
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groups.  Participants in the control group received bupivacaine with normal saline and 
participants in the experimental group received bupivacaine with dexmedetomidine.  
Data was collected postoperatively by patients’ self-report of pain using a NRS of 1-10, 
10 being the worst pain.  At a score of 4, rescue analgesic was administered.  The 
researchers assessed how long it took for the first dose of rescue analgesic to be 
administered.  After analyzing the data researchers found the time to first analgesia was 
significantly prolonged in the experimental compared to the control group (p < 0.0001).  
Nazir and Jain (2016) concluded that dexmedetomidine is an effective adjuvant to 
bupivacaine.  
Next, the theoretical framework utilized for this systematic review will be 
presented. 
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Theoretical Framework 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) statement was designed to assist in the quality of reporting of controlled trials.  
A systematic review is an analysis of a relevant research question that uses systematic 
methods to identify, select, and appraise relevant research (Moher, Liberati, Tetzlaff, 
Altman, & PRISMA Group, 2009).  In a meta-analysis, statistical data is used to analyze 
and summarize the results.  Systematic reviews and meta-analyses serve a significant 
purpose in healthcare.  The results of various studies can be reviewed and summarized so 
relevant information can be extracted and reported.  Writing a systematic review can be a 
complex and challenging task, therefore the PRISMA statement was developed to assist 
and improve the process of reporting. 
The PRISMA statement evolved from the Quality of Reporting of Meta-analyses 
(QUOROM) statement in 2005.  QUOROM is a guideline for appraising meta-analyses. 
The goal of expansions was to include systematic reviews as well.  The PRISMA 
statement consists of a 27-item checklist and a flow diagram with four phases (Moher et 
al., 2009).  The PRISMA checklist (Appendix A) guides you through a series of steps to 
assist with evaluation of a study.  The steps are grouped into seven sections: title, 
abstract, introduction, methods, results, discussion, and funding.  Each section is further 
divided into topics.  This checklist will be utilized by the author to assure completeness 
of the systematic review. 
The PRISMA statement also contains a flow diagram (Appendix B) that is a 
model used for depicting phases of a systematic review.  It depicts the stages of 
identification, screening, eligibility, and studies included.  
15 
 
All research is valuable to clinical practice and the importance of that research 
relies on what was done, what was found, and the clarity of information (Moher et al., 
2009).  The PRISMA statement was utilized by the author during production of the 
systematic review. 
The CASP checklist (Appendix C) was also utilized to critically appraise the data.  
This tool proposes a systematic process to assist with identifying strengths and 
weaknesses of a research study (Singh, 2013).  The CASP tool has several checklists, 
each for a specific type of research study.  The checklist designed for a systematic review 
was utilized for this paper and will be described further in the methods section.   
 The methods of this systematic review will be discussed next. 
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Methods 
 
Purpose 
 The purpose of this paper is to complete a systematic review to determine if the 
administration of intrathecal dexmedetomidine, as an adjuvant medication to 
bupivacaine, impacts postoperative pain in adult patients undergoing surgery. 
The research question to be examined in this review is: Does the administration of 
intrathecal dexmedetomidine, as an adjuvant medication to bupivacaine, decrease time to 
first analgesia, in postoperative adult patients? 
Inclusion and Exclusion Criteria 
 Inclusion criteria consisted of randomized controlled trials published in the last 
ten years, written in the English language, participants 18 years or older and undergoing a 
surgical procedure in which dexmedetomidine was used as an adjunctive to intrathecal 
bupivacaine.  Exclusion criteria included participants younger than 18 years old, articles 
that used adjuvant medications other than dexmedetomidine, and articles that used local 
anesthetics other than intrathecal bupivacaine.   
Search Strategy 
 The PRISMA checklist and flow diagram were used to guide the search strategy.  
Research was collected using the databases CINAHL, Medline, and PubMed.  The search 
terms used were: dexmedetomidine, postoperative pain, and intrathecal bupivacaine.  The 
articles were screened for inclusion and exclusion criteria.  Studies were chosen based on 
the title, the abstract and whether it correlated with the purpose of this paper which was 
to complete a systematic review to determine if the administration of intrathecal 
17 
 
dexmedetomidine, as an adjuvant medication to bupivacaine, impacts postoperative pain 
in adult patients undergoing surgery.  
Data Collection and Synthesis 
Each article was carefully read and pertinent information was extracted.  Data was 
entered into two tables created by the author of this systematic review.  The data tables  
summarize information that is easily interpretable.  Data collected and displayed in Table 
1 include purpose, setting, sample size, and design method.  Data collected and displayed 
in Table 2 include procedure, pain scale used, results, and limitations of the study. 
Table 1. 
Data Collection Tool 1 
Purpose Setting Sample Design Method 
 
  
Table 2. 
 
Data Collection Tool 2 
 
Procedure Pain Scale Used Results Limitations 
 
Critical Appraisal Tool 
 The CASP checklist was used to guide the critical appraisal of selected articles.  It 
consists of three sections, totaling eleven questions that are used to guide the review 
process.  
Section A asks if the results are valid.  This section starts with two questions that 
are referred to as screening questions, which can be answered quickly and easily but must 
be addressed before moving on.  Once it is determined the results are valid, the next 
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section addresses what the results are.  Section B asks two questions: What are the overall 
results of the review, and the second asks how precise the results are.  Lastly, Section C 
addresses whether the results will be helpful locally and whether the results are feasible.  
Prompts are given throughout the three sections to facilitate answering the questions.  
The CASP tool was used to systematically evaluate each article and its results. 
The guidelines are clear and concise, making it easy to understand.  The questions are 
wide ranging and offer direction, facilitating a structured approach to analyzing evidence 
(Singh, 2013). 
Cross Analysis 
A cross study analysis was performed that compared the effects of 
dexmedetomidine to the time of first analgesic request postoperatively as well as type of 
procedure, pain measurement tool, and dosage of medications used in each study.  A 
table was formulated to compare the results of the control group compared to the 
intervention group across studies (Table 3).  The similarities and differences between the 
studies will be compared.   
Table 3. 
Cross Study Analysis 
Authors  Procedure/Type 
of surgery 
Pain 
Measurement 
Tool 
Dosage 
Used 
Control 
Group- 
mean time 
to first 
analgesic 
request 
(minutes) 
Intervention 
Group- mean 
time to first 
analgesic 
request 
(minutes) 
 
Next, the results will be discussed. 
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Results 
Data Collection 
The PRISMA flow diagram was utilized to guide the search for pertinent 
literature.  Multiple databases were used to identify pertinent records, and duplicates were 
excluded.  An initial broad search was performed using the term “dexmedetomidine”. 
Search results showed 1,287 results through CINAHL, 4,214 through PubMed, and 4,510 
through Medline.  The search was then narrowed by applying the secondary term 
“postoperative pain”.  Results from CINAHL, PubMed, and Medline dropped to 165, 
233, and 549 respectively.  The search was narrowed once more by adding the term 
“bupivacaine”.  CINAHL, PubMed, and Medline results dropped further to 27, 36, and 75 
respectively.  The records were then screened for availability of full text, and further 
screened for inclusion and exclusion criteria.  After eligibility of articles was determined, 
the number of RCTs were totaled and accounted for.  Six RCTs were chosen for review 
(Figure 1). 
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Figure 1. PRISMA Flow Diagram 
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An RCT by Kim, Kim, Lee, and Kil (2013) assessed 54 elderly patients 
undergoing transurethral resection of the prostate (TURP) under a spinal anesthetic using 
low dose bupivacaine.  The authors calculated a sample size of 23 patients in each group 
would be required to achieve power of 80% and a significance level of 0.05.  A random 
allocation sequence was used to assign groups: the experimental group received spinal 
dexmedetomidine in addition to bupivacaine and the control received only bupivacaine. 
A spinal puncture was performed with the patient in the lateral decubitus position at the 
3rd-4th or 4th-5th interbody lumbar space with a midline approach using a 25-gauge 
Quincke needle.  After confirmation of CSF flow the pre-prepared drug was administered 
and the patient was placed in the supine position.  Those in the experimental group 
received 3 micrograms (mcg) of dexmedetomidine combined with 6 milligrams (mg) of 
hyperbaric bupivacaine, while the control group received 6 mg of bupivacaine with 3 
mcg of saline.  Following the procedure, the patient was brought to the post-anesthesia 
recovery unit (PACU) where the time until first analgesic request was recorded.  Pain 
levels were assessed using the VAS at 30 minutes post-operatively, and again at 6 hours, 
24 hours, and 36 hours after discharge.  The authors found the number of patients 
requiring postoperative analgesics was similar between the two groups, but the 
dexmedetomidine group had fewer overall requirements for rescue analgesic medications 
with a p value <0.01.  The mean time to first analgesic request in the control group was 
345 minutes, compared to the experimental group, which was 1360 minutes.  Kim et al. 
(2013) also reported that time to first analgesic was longer in the dexmedetomidine 
group, p =0.039 (Appendix D).  
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  Abdelhamid and El-lakany (2013) assessed 62 patients presenting for inguinal 
hernia repair over a three-month period.  Patients were ages 18-60 years old.  Patients 
were randomized into one of two groups using the sealed envelope technique.  One group 
received 3.5 ml of bupivacaine with 5 mcg of dexmedetomidine, and the other group 
received 3.5 ml of bupivacaine with normal saline.  A 25-gauge pencil point needle was 
inserted through the 4th-5th interbody lumbar space and medication was injected over 10 
seconds.  Postoperatively, the amount of time until first analgesic request was recorded. 
Total analgesic consumption over 24 hours was also recorded.  No pain scale was used.  
The authors found that analgesic requirements were significantly lower in the group that 
received the bupivacaine and dexmedetomidine and reported a p value of <0.0001.  Total 
analgesic consumption was also lower in the group that received bupivacaine with normal 
saline (p value of <0.0001).  The mean time until first analgesic request was 259 minutes 
in the group that did not receive dexmedetomidine, compared to 381 minutes in the group 
that did receive the dexmedetomidine (Appendix E). 
 Bi, Cui, Zhang, Song, and Zhang (2017) assessed 60 patients presenting for 
elective cesarean section undergoing spinal anesthesia.  Patients were of ASA status 1 or 
2, ages ranged from 18-40.  Patients were randomized into one of three groups using a 
computer-generated randomization table.  One group received 10 mg of bupivacaine 
alone, the second group received 10 mg of bupivacaine with 3 mcg of dexmedetomidine, 
and the third group received 10 mg of bupivacaine with 5 mcg of dexmedetomidine.  
Lumbar epidural anesthesia was induced using a 25-gauge pencil point needle.  The drugs 
were injected at a rate of 1ml/15 seconds, and each spinal was administered by the same 
anesthesiologist.  Postoperative pain was assessed using the VAS at 6 and 12 hours after 
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surgery.  The time to first rescue analgesic was also recorded.  The authors found that 
pain ratings at 6 hours were higher in the group that received bupivacaine alone (p value 
= 0.0032).  There was no difference between the groups at 12 hours (p=0.3533).  
Additionally, the time to first rescue analgesic was not significantly different (p=0.7096).  
The mean time to first request for analgesia was 1320 minutes in the group that received 
no dexmedetomidine, compared to 1488 minutes and 1428 minutes in the groups that 
received 3mcg and 5mcg of dexmedetomidine respectively (Appendix G).    
Patro, Deshmukh, Ramani, and Das (2016) conducted a study of 60 patients 
undergoing infra-umbilical surgery with spinal anesthesia.  The types of infra-umbilical 
surgeries included in the study were hysterectomies, hernia repairs, appendectomies, and 
open urosurgical procedures.  Participants were ages 18-45 and ASA status 1 or 2.  Data 
was collected over a two-month period.  The participants were randomly allocated into 
two groups using the sealed envelope technique.  Group one received 3ml of 0.5% 
hyperbaric bupivacaine with 0.5ml of normal saline.  Group two received 3ml of 0.5% 
hyperbaric bupivacaine with 5mcg of dexmedetomidine.  The medication was prepared 
by an anesthesiologist not involved in the study.  Lumbar puncture was performed with 
the patient in left lateral decubitus position with a 25-gauge needle inserted at the L3-L4 
intervertebral space.  VAS was recorded postoperatively at three, six, and twelve hours.  
Rescue analgesics were administered when VAS was greater than three.  The cutoff point 
for the study was when the patient required the first dose of rescue analgesia.  The 
authors found a significant difference in duration of analgesia between the two groups.  
After three hours, the mean VAS in group one was 1.03 and 0.03 in group two.  At six 
hours, the mean VAS in group two was 2.67 and 3.7 in group one (p < 0.001).  The mean 
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time until first analgesic request postoperatively was 269 minutes in group one and 399 
minutes in group two.   
 Salem, Darweesh, Wanis, and Mohamed (2015) assessed 52 patients undergoing 
posterolateral lumbar spinal fusion with intrathecal anesthesia.  Participants were ages 
40-65 years old and ASA status 1 or 2.  Participants were separated into one of two 
groups using the sequentially numbered closed envelopes.  Group one received 15mg of 
hyperbaric bupivacaine with 5mcg of dexmedetomidine.  Group two received 15mg of 
hyperbaric bupivacaine with 0.5ml of saline.  Lumbar puncture was performed in sitting 
position at the level of L3-L4 intervertebral disc space.  A 25-gauge needle was used, and 
the same anesthesiologist performed all spinals.  Also, the same surgeon performed all 
surgeries.  Postoperatively, the total dose of analgesic medication over 24 hours was 
recorded.  The authors found that time to first analgesic request was significantly longer 
in group one ( p <0.0001).  Salem et al. (2015) also found the total dose of analgesic 
medication over 24 hours was smaller in group one (p < 0.0001).  The mean time until 
first analgesic request was 399 minutes in group one, compared to 269 minutes in group 
two (Appendix H).   
 Yetkas and Belli (2014) assessed 60 male patients undergoing inguinal surgery 
under spinal anesthesia.  Participants were between the ages of 20-30 years old.  Patients 
were divided randomly into three groups.  Group one received 15mg of hyperbaric 
bupivacaine with 0.5ml of normal saline; group two received 15mg of hyperbaric 
bupivacaine with 2mcg of dexmedetomidine; and group 3 received 15mg of hyperbaric 
bupivacaine with 4mcg of dexmedetomidine.  Lumbar puncture was performed with the 
patient in a sitting position.  A 25-gauge spinal needle was inserted into the L4-L5 disc 
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space, and when CSF flow was observed the pre-prepared medical solution was injected.  
Postoperatively the time until onset of pain was recorded, as well as the total amount of 
analgesic medication administered over 24 hours.  The authors found that time until 
initiation of pain was significantly longer in group three than in groups one and two (p < 
0.001).  They also found that analgesic medication consumption over 24 hours was 
significantly higher in group one than in groups two and three (p < 0.001).  The mean 
time until first analgesic request was 220 minutes in group one, 371 minutes in group 
two, and 1042 minutes in group three (Appendix F).   
Critical Appraisal 
The six randomized control trials discussed in this paper were critically appraised 
using CASP.   
In the study by Kim et al. (2013) a total of 54 elderly patients were randomized 
into one of two groups to evaluate the adjuvant effects of intrathecal dexmedetomidine 
with bupivacaine on postoperative pain.  All the critical analysis questions were scored 
“yes” except one question that asked if groups were similar at the start of the trial.  
Patients underwent the same surgery and 39 out of 54 participants had more than one 
systemic disease, but these systemic diseases were not further distinguished between the 
two groups.  It was unclear if the two groups were similar at the start of the study.  The 
patients, healthcare workers, and study personnel were all blinded to the treatment.  All 
participants were treated equally throughout the study (Appendix J).   
In the Abdelhamid and El-lakany (2013) study, all participants were randomly 
divided into two groups using the sealed envelope technique.  Most critical appraisal 
questions were answered “yes” except for two.  One asked if groups were similar at the 
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start of the trial.  Participant ages varied significantly, between 22-56 years old, and the 
distribution between groups was unclear.  Second, all clinically important outcomes were 
not considered.  Immediate outcomes were considered, but nothing beyond the immediate 
post-operative period was assessed.  There was no documented follow up with any of the 
participants.  Participants, healthcare workers, and study personnel were all blinded to the 
treatment.  Groups were treated equally throughout the study (Appendix K).   
 In the study by Bi et al. (2017) all critical appraisal questions were scored “yes” 
except for one that asked if all the participants who entered the trial were accounted for at 
its conclusion.  During the study if spinal anesthesia failed, participants would be 
excluded.  The authors did not identify how many spinals failed, and they did not specify 
how many participants finished the study.  All personnel involved with the study were 
blinded and the groups were treated equally.  All clinically important outcomes were 
considered (Appendix L). 
  In the study by Patro et al. (2016) all critical appraisal questions were scored 
“yes”.  Participants, healthcare workers, and study personnel were blinded to the 
treatment.  Both groups were treated equally, and all important clinical outcomes were 
considered (Appendix M).   
 In Salem et al.’s (2015) study, a total of 52 participants were randomized and 
enrolled into one of the two groups.  All personnel involved with the study were blinded 
to the treatment.  Groups were similar at the start of the study.  Although, it was unclear 
if the groups were treated equally; no information was provided by the authors.  All 
clinically important outcomes were considered and no adverse outcomes were noted in 
the intervention group (Appendix N).  
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 In the study by Yetkas and Belli (2014), a total of 60 participants were 
randomized and enrolled into one of the three groups.  All critical appraisal questions 
were scored “yes” except for one that asked if the benefits were worth the harm and cost.  
This study found clear benefits of using dexmedetomidine with hyperbaric bupivacaine 
intrathecally with no additional harm to the patient; however, no cost analysis was 
addressed.  All participants, healthcare workers, and study personnel were blinded to the 
treatment.  Groups were similar at the start and treated equally throughout the study 
(Appendix O). 
Cross Analysis 
 The randomized control trials of this systematic review were analyzed across 
studies (Appendix P).  The cross analysis compared the effects of dexmedetomidine to 
the time of first analgesic request postoperatively as well as dose of dexmedetomidine 
used, type of surgery, and pain scale used. 
 All randomized control trials included in this systematic review investigated 
different surgeries.  The anesthesia provided for the surgery was the same (spinal 
anesthesia) but surgical procedures varied.  Kim et al. (2013) investigated patients 
undergoing transurethral prostatectomy; Abdelhamid and El-lakany  (2013) investigated 
lower abdominal surgeries; Yektas and Belli (2014) investigated inguinal surgeries; Bi et 
al. (2017) investigated cesarean section; Salem et al. (2015) investigated posterolateral 
lumbar spinal surgeries and; Patro et al. (2016) investigated infraumbilical surgeries.  All 
studies reported improved postoperative pain in the intervention groups.  Even though the 
surgeries being performed were different in each study, the results supported the 
hypothesis that intrathecal dexmedetomidine would improve postoperative pain. 
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Another aspect of each study that was analyzed was the type of pain scale used.  
Three of the randomized control trials used the VAS, one used the numerical rating scale, 
and two used no scale at all, instead measuring time in minutes to first analgesic request.  
As stated earlier, these different methods of evaluating pain are all reliable.  Results were 
similar across all studies, regardless of the type of scale used. 
 Another aspect compared across studies was time to first analgesic request in the 
control group versus intervention group.  All the randomized control trials in this 
systematic review reported improved postoperative pain when dexmedetomidine was 
added to intrathecal bupivacaine.  This was shown clearly in the cross-analysis table, 
represented by longer mean time until first analgesic request.  The longer it took for 
patients to request pain medication in the postoperative period, the longer intrathecal pain 
relief lasted.  The most significant results were found in the study by Kim et. al (2013).  
Mean time to first analgesic request in the control group was 345 minutes, and in the 
intervention group it was 1360 minutes.  These results showed a significant difference 
between the two groups (p=0.006).  
 The last aspect compared across studies was the dosage of dexmedetomidine 
used.  The dosages of dexmedetomidine across studies ranged from 2-5 mcg.  All doses 
were associated with decreased postoperative pain, but the study by Kim et al. (2013) had 
the most significant results.  This trial used a dose of 3mcg of dexmedetomidine.  This 
was not the highest dose used, yet it yielded the most significant results.  This proposes 
that even lower dosages of the medication can have profound effects in decreasing 
postoperative pain levels and a higher dose may not be necessary.  
Next, the summary and conclusions section will be presented. 
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Summary and Conclusions 
 Postoperative pain continues to be a substantial issue in the healthcare field.  As 
stated earlier, it is inadequately managed in the majority of patients.  Postoperative pain 
directly correlates with negative patient outcomes and increased hospital costs.  
Traditional management of postoperative pain consists of parenteral opioids, which are 
associated with numerous adverse side effects (Banks, 2007).  The nurse anesthetist 
should utilize all modalities of pain relief throughout surgery to improve postoperative 
pain.  One method is to use local anesthetics and adjuvants to local anesthetics, such as 
dexmedetomidine.   
 Local anesthetics may be used in a variety of clinical settings for treating mild to 
severe pain (Banks, 2007).  Furthermore, the addition of dexmedetomidine to local 
anesthetics can make an immense difference in postoperative analgesia and recovery.  
The purpose of this paper was to complete a systematic review to determine if the 
administration of intrathecal dexmedetomidine, as an adjuvant medication to 
bupivacaine, impacts postoperative pain in adult patients undergoing surgery.   
 A literature review was conducted utilizing inclusion and exclusion criteria 
generated by the author.  The databases CINAHL, Medline, and PubMed were utilized 
for the search.  The PRISMA flowchart was used to guide the search strategy.  A total of 
six randomized control trials were selected for inclusion.  Each article was carefully read 
and pertinent information was extracted.  Data collection tables were formulated for all 
articles.  Information collected from each article included purpose, setting, sample, 
design method, procedure, pain scale used, results, and limitations.  Following data 
collection, a critical appraisal was performed on the selected articles.  The CASP 
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checklist was used to guide the critical appraisal.  Analysis across studies focused on the 
type of surgery, the pain scale used, and mean time to first analgesic request for control 
and intervention group. 
 All six randomized control trials in this systematic review reported improved 
postoperative pain when dexmedetomidine was added to intrathecal bupivacaine.  Overall 
analgesia requirements were lower in all intervention groups.  The most significant 
results were found in the study by Kim et al (2013).  These results showed a significant 
difference between the two groups (p=0.006).  Time to the first requirement of analgesia 
was significantly longer in the intervention group.   
 After thorough evaluation of the literature, limitations to this systematic review 
were identified.  The primary limitation to this systematic review was that each control 
trial evaluated different surgical techniques.  The argument could be made that variations 
in surgical procedures have different expectations for postoperative pain, therefore the 
results may not be generalized across procedures.  While the results were the same for 
each trial, a stronger correlation could have been made if the surgical procedures were the 
same across all studies.  Another limitation was the fact that different doses of 
dexmedetomidine were used in several of the RCTs.  The use of dexmedetomidine 
showed improved postoperative pain, but the ideal does needs to be further investigated.  
In addition to these limitations, ages of the study populations also varied.  All participants 
across studies were healthy, ASA status 1 or 2, but ages varied greatly.  Between all six 
studies, ages varied from 18 to 65.  Participants of similar age groups may have made the 
results more generalizable.  Although these limitations existed, the purpose of this 
systematic review was achieved. 
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 Despite limitations, this systematic review provides evidence that intrathecal 
dexmedetomidine as an adjuvant to bupivacaine will improve postoperative pain.   
Next, recommendations and implications for advanced practice nursing will be discussed.  
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Recommendations and Implications for Advanced Nursing Practice 
 Management of postoperative pain is an important aspect of care for every 
surgical patient.  Certified Registered Nurse Anesthetists (CRNAs) play an integral role 
in the management of postoperative pain.  Adequate pain control is a crucial component 
of patient recovery.  Pain can diminish a patient’s ability to participate in postoperative 
interventions such as coughing, deep breathing, and ambulating (Francis & Fitzpatrick, 
2012).  All these interventions can facilitate a fast, un-complicated recovery and improve 
patient outcomes.   
 There are many methods used to treat postoperative pain.  These methods are key 
in facilitating positive patient outcomes following surgical procedures.  There is no 
consensus on the best method for controlling pain, but health care providers must stay 
abreast of current methods used for postoperative pain management (Banks, 2017).  One 
method to control postoperative pain is administration of spinal anesthesia.  This method 
is regularly used by CRNAs for a variety of surgical procedures.  There are standard 
medications recommended for use intrathecally, including bupivacaine.  Of recent years, 
there has been increased use of adjuvant medications used intrathecally.  One of these 
adjuvant medications is dexmedetomidine.   
 This systematic review researched the most current evidence regarding the use of 
dexmedetomidine as an adjuvant to intrathecal bupivacaine.  The review provides 
evidence that intrathecal dexmedetomidine, as an adjuvant to bupivacaine, will improve 
postoperative pain.  Applying this evidence to practice is the next step.  Anesthesia 
providers need to be educated on the valuable effects of this intervention.  Once 
education has taken place, the intervention can be applied at the clinical level.  Once the 
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intervention is applied, patients should be evaluated in the postoperative period for both 
positive and negative effects of intrathecal dexmedetomidine.  This change in practice 
would be a simple one to implement if adequate education was provided to the anesthesia 
care team. 
It is important that CRNA practice is evidence-based.  For years, systematic 
reviews have been utilized by Advanced Practice Nurses to formulate guidelines of care.  
This systematic review could aid in future research regarding improved management of 
postoperative pain.   
 The use of dexmedetomidine as an adjuvant to intrathecal bupivacaine has been 
proposed, but further research and education needs to be provided on the topic.  Further 
research about the dose of dexmedetomidine would be beneficial.  All trials proposed in 
this review used slightly different doses of dexmedetomidine, and all addressed the need 
for further research on the matter.  Identifying a specific dose could improve guidelines 
for easier implementation.   
 Future recommendations include the addition of adjuvant medications to local 
anesthetics intraoperatively.  Published studies have supported the hypothesis that 
dexmedetomidine as an adjuvant medication to intrathecal bupivacaine will improve 
postoperative pain.  Although more research on the dose of dexmedetomidine is required, 
benefits of the intervention have been supported.   
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Appendix B 
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Appendix D 
Table 1 
 Kim, J.E., Kim, N.Y., Lee, H.S., & Kil, H.K. (2013). Effects of intrathecal 
 dexmedetomidine on  low-dose bupivacaine spinal anesthesia in elderly patients 
 undergoing transurethral prostatectomy. The Pharmaceutical Society of Japan, 
 36(6), 959-965. 
 
Table 2 
Procedure Pain Scale Used/ Results Limitations 
Purpose Setting Sample Design Method 
-Evaluate adjuvant 
effects of intrathecal 
dexmedetomidine in 
elderly patients 
undergoing TURP 
surgery with low dose 
bupivacaine spinal 
anesthesia 
-Primary end-point: 
time to regression of 2-
sensory dermatomes 
from peak sensory 
block level 
-Secondary end-points: 
motor block scales at 
peak sensory block and 
postoperative analgesic 
requirement 
-Approved by 
the Institutional 
Ethics 
Committee of 
Yonsei 
University 
Health System of 
Japan 
-Conducted at 
one hospital 
-54 elderly 
patients, ages 60-
74 
-Patient 
characteristics 
were similar; 
39/54 had more 
than one systemic 
disease   
-All patients 
completed study  
-Participants 
randomized into 
one of two groups: 
a group that 
received 3mcg of 
dexmedetomidine 
combined with 
6mg of hyperbaric 
bupivacaine, and 
another group that 
received the same 
amount of NS and 
bupivacaine 
-A random number 
sequence was used 
-In the PACU, the 
time to first 
analgesic request 
was recorded 
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TURP surgery. 
Spinal puncture 
was performed at 
L3-4 or L4-5 with 
a midline 
approach using a 
25G Quincke 
needle in the 
lateral decubitus 
position.  After 
confirmation of 
free flow and 
clear 
cerebrospinal 
fluid, the drug 
was administered, 
and patient was 
placed in the 
supine position. 
-VAS  
-assessed pain 
level: arrival to 
PACU, 30 minutes 
after arrival, and 
then 6h, 24h, and 
36h after discharge. 
-Time to first 
analgesic request 
was recorded. 
Number of 
patients requiring 
postoperative 
analgesics 
weren’t different 
between the two 
groups, but 
dexmedetomidine 
group had less 
requirements for 
postoperative 
rescue analgesics 
(p < 0.01) 
-Time to request 
for first analgesic 
was longer in 
dexmedetomidine 
group (p 0.039) 
-3mcg of 
dexmedetomidine 
added to 
bupivacaine 
prolonged 
postoperative 
analgesia 
-mean time to 
first analgesic 
request was 345 
minutes in control 
group and 1360 
minutes in 
intervention 
group 
Three participants in the 
control group required 
fentanyl supplementation 
during the procedure; 
intervention not applied to 
all participants 
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Appendix E 
Table 1 
 Abdelhamid SA, El-lakany MH (2013) Intrathecal dexmedetomidine: Useful or not? J 
 Anesth  Clin Res 4:351.  
Table 2 
Procedure Pain Scale 
Used 
Results Limitations 
-25-gauge 
pencil point 
spinal needle 
was inserted 
through L4-L5 
interspace 
-Injections 
given over 10 
seconds 
-no pain scale 
used 
-results were 
assessed by 
evaluating time 
to analgesic 
request 
-analgesia 
requirements lower 
in group D 
(p<0.0001) 
-total analgesic 
consumption was 
lower in group D 
(p<0.0001) 
-mean time to first 
analgesic in group 
1 was 259 min, and 
381 min in group 2 
 
-no pain scale was used 
-no information on how pain 
assessment was conducted 
Purpose Setting Sample Design Method 
-Evaluate role of 
dexmedetomidine 
when added to heavy 
bupivacaine 
-assess time to require 
first analgesic 
-assess total analgesic 
consumption 
-Approved by the 
Ethical 
Committee of the 
Medical Research 
Institute of 
Alexandria 
University 
Conducted at one 
hospital 
-62 patients 
presenting for 
inguinal hernia 
repair 
-during period of 
January 1, 2013 to 
end of March 2013 
-ages 18-60 
-exclusion criteria: 
neurological 
disease, 
coagulopathy, 
cardiac disease, 
obesity, 
hypertension 
-patients 
randomized into 
one of two groups 
using sealed 
envelope technique 
-group one: 3.5ml 
of hyperbaric 
bupivacaine and 
5mcg of 
dexmedetomidine 
-Group two: 
normal saline 
added to 
hyperbaric 
bupivacaine  
-first time to 
require analgesia 
was recorded 
-total analgesic 
consumption was 
recorded over 24 
hours 
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Appendix F 
Table 1 
Yektaş, A., & Belli, E. (2014). The effects of 2 μg and 4 μg doses of dexmedetomidine in 
 combination with intrathecal hyperbaric bupivacaine on spinal anesthesia and its 
 postoperative analgesic characteristics. Pain Research & Management: The 
 Journal of the Canadian Pain Society, 19(2), 75–81. 
Purpose Setting Sample Design Method 
-compare 
postoperative 
analgesic 
characteristics of 
dexmedetomidine 
added to hyperbaric 
bupivacaine 
-compare side effects 
when 
dexmedetomidine is 
added to intrathecal 
bupivacaine 
-evaluate effects of 
intrathecal 
dexmedetomidine on 
spinal anesthesia 
-study was approved 
by the local ethics 
committee of First 
University Medical 
Faculty of Turkey 
-conducted in a 
military hospital 
-60 male patients 
undergoing inguinal 
surgery 
-between 20-30 
years old 
-exclusion criteria: 
addicted to drugs, 
required additional 
analgesia, sedation 
during previous 
procedures, 
experienced pain 
with previous 
procedures, patients 
whom they were 
unable to obtain 
CSF, and patients 
whose level of 
education was below 
graduation from 
primary school 
-patients were 
randomly divided 
into three groups 
-Group 1: 15mg of 
hyperbaric 
bupivacaine plus 
0.5ml saline 
-Group 2: 15mg of 
hyperbaric 
bupivacaine plus 2 
mcg 
dexmedetomidine 
-Group 3: 15mg of 
hyperbaric 
bupivacaine plus 
4mcg 
dexmedetomidine 
-pain onset time in 
postoperative period 
was recorded 
-total amount of 
analgesic medication 
for 24 hours was 
recorded 
 
Table 2 
Procedure Pain Scale 
Used 
Results Limitations 
-patient in 
sitting position; 
25-gauge 
Quincke spinal 
needle inserted 
into the L4-L5 
disc space 
 -numerical 
pain rating 
scale 
-time to initiation of pain 
was significantly longer in 
group 3 than in both groups 
1 and 2 (P<0.001) 
-analgesic medication 
consumption over 24 hours 
was significantly higher in 
None stated 
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-when CSF 
flow observed, 
prepared 
medical 
solution was 
injected 
group 1 than in groups 2 and 
3 (P<0.001) 
-mean time to first analgesic 
in group 1 was 220 min., 
group 2 371 min., and group 
3 1042 min 
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Appendix G 
Table 1 
Bi, Y.-H., Cui, X.-G., Zhang, R.-Q., Song, C.-Y., & Zhang, Y.-Z. (2017). Low dose of 
 dexmedetomidine as an adjuvant to bupivacaine in cesarean surgery provides 
 better intraoperative somato-visceral sensory block characteristics and 
 postoperative  analgesia. Oncotarget, 8(38), 63587–63595.  
Purpose Setting Sample Design Method 
Measure effects of 
lower doses of 
dexmedetomidine 
with intrathecal 
bupivacaine on 
postoperative pain 
-approved by the 
institutional ethics 
committee in 
China 
-60 participants 
-women of ASA 
physical status 1 or 
2 
-pregnant and 
receiving spinal 
anesthesia for 
elective c-section 
-ages 18-40 
-exclusion criteria: 
history of opioid 
use or NSAIDS, 
psychiatric 
disorders, 
preoperative HR 
<50 bpm, 
neuromuscular or 
endocrine disease, 
or allergy to alpha 
2 agonists 
-prospective, 
randomized, double 
blind study 
-a computer 
generated 
randomization table 
was used 
-Bup Group: 10mg 
bupivacaine alone 
-Bup+Dex3 Group: 
10mg bupivacaine 
with 3mcg 
dexmedetomidine 
-Bup+Dex5 Group: 
10mg bupivacaine 
with 5mcg 
dexmedetomidine 
 
Table 2 
Procedure Pain Scale 
Used 
Results  Limitations 
-lumbar epidural 
anesthesia was 
induced 
-spinal injection 
performed with 
a 25-gauge 
pencil point 
needle and 
injection was 
made 
-VAS 
-assessed 6 and 
12 hours after 
surgery 
-first rescue 
analgesia drug 
time was 
recorded 
-VAS at 6 hours was higher 
in Bup Group than the other 
two groups (P=0.0032) 
-No difference was observed 
at 12 hours (P=0.3533) 
-time to first postoperative 
supplemental drug 
administration was not 
significantly different 
(P=0.7096) 
-mean time to first analgesic: 
None stated 
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-study drugs 
were injected at 
a rate of 
1ml/15sec 
-same 
anesthesiologist 
administered 
each spinal 
 Bup Group: 1320 
min 
 Bup+Dex3: 1488 
min 
 Bup+Dex5: 1428 
min 
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Appendix H 
Table 1 
Salem, R.A., Darweesh, E.I., Wanis, M.A., & Mohamed, A.A. (2015). Evaluation of the 
 effects  of intrathecal bupivacaine-dexmedetomidine for lumbar spine fusion: a 
 double blinded randomized controlled study. European Review for Medical and 
 Pharmacological Sciences, 19, 4542-4548. 
Purpose Setting Sample Design Method 
-evaluate efficacy of 
intrathecal 
dexmedetomidine at 
improving 
postoperative 
analgesia during 
spinal surgery 
-also investigated 
effects of 
dexmedetomidine 
on patient 
hemodynamics 
-approved by the 
Ethics and 
Research 
Committee of 
Sohag Faculty 
Faculty of 
Medicine, Sohag 
University 
-conducted at 
Sohag University 
Hospital 
-August 2012-July 
2014 
-52 patients 
-ages 40-65 years 
-ASA physical 
status 1 or 2 
-scheduled for one-
level posterolateral 
lumbar spine fusion 
-exclusion criteria: 
contraindication for 
spinal anesthesia, 
known allergy to 
study drugs, 
treatment with 
alpha adrenergic 
antagonists, labile 
hypertension, 
cardiac 
dysrhythmias, 
coronary artery 
disease, renal or 
hepatic impairment, 
neurological 
disorder, or 
bleeding diathesis 
-prospective, 
randomized, double-
blind, placebo-
controlled clinical 
study 
-participants were 
randomized using 
sequentially 
numbered closed 
envelopes 
-Group D: 15mg 
hyperbaric 
bupivacaine with 
5mcg of 
dexmedetomidine 
-Group P: 15mg 
hyperbaric 
bupivacaine with 
0.5ml saline 
-time to first 
requirement of 
analgesia was 
recorded 
-total dose of 
analgesic 
medication over 24 
hours was recorded 
 
Table 2 
Procedure Pain Scale 
Used 
Results Limitations 
-Lumbar 
puncture 
performed with 
patient in sitting 
-no pain scale 
used 
-results were 
assessed by 
-time to first 
analgesic 
request was 
significantly 
None stated 
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position at L3-
L4 intervertebral 
disc space 
-25-gauge 
needle 
-same surgeon 
performed all 
operations 
-same 
anesthesiologist 
performed all 
spinals 
evaluating time 
to analgesic 
request 
longer in group 
D (p<0.0001) 
-total dose of 
total analgesic 
medication over 
24 hours was 
smaller in 
group D 
(p<0.0001) 
-mean time to 
first analgesic 
in group P was 
269 min, and 
group D was 
399 min 
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Appendix I 
Table 1 
Patro, S.S., Deshmukh, H., Ramani, Y.R., & Das, G. (2016). Evaluation of 
 dexmedetomidine as an adjuvant to intrathecal bupivacaine in infraumbilical 
 surgeries. Journal of Clinical and Diagnostic Research, 10(3), 13-16. 
Purpose Setting Sample Design Method 
-evaluate efficacy of 
intrathecal 
dexmedetomidine as 
an adjuvant to 
bupivacaine in 
spinal anesthesia in 
patients undergoing 
infraumbilical 
surgery 
-study approved by 
Institutional Ethics 
Committee of 
Odisha, India 
-conducted at one 
hospital 
-over a 2-month 
period 
-60 adult patients 
of either sex 
-ages 18-45 
-ASA 1 and 2 
-exclusion criteria: 
coagulation 
disorders, 
neurologic 
disorders 
-prospective, double 
blind 
-randomly allocated 
into two groups 
using sealed 
envelope technique 
-Group I: 3ml of 
0.5% hyperbaric 
bupivacaine and 
0.5ml normal saline 
-Group II: 3ml of 
0.5% hyperbaric 
bupivacaine with 
5mcg 
dexmedetomidine 
-level of analgesia in 
postoperative period 
was recorded 
 
Table 2 
Procedure Pain Scale Used Results Limitations 
-surgery was 
approximately one 
and a half hour 
-medication 
prepared by 
anesthesiologist not 
involved in study 
-lumbar puncture 
performed in left 
lateral position 
-25 gauge Quincke 
needle inserted at 
L3-L4 intervertebral 
space 
-VAS -significant 
difference in 
duration of 
complete analgesia 
observed between 
two groups 
-intra-operative 
VAS was <3 in 
both groups 
-after three hours 
VAS 0.03 in Group 
II and 1.03 in 
Group I 
-after six hours 
VAS 2.67 in Group 
-small sample size 
-2-month period 
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-3.5ml of pre-
prepared drug 
administered 
-infraumbilical 
surgeries: 
hysterectomy, hernia 
repairs, 
appendectomy, open 
urosurgical 
procedures 
II and 3.7 in Group 
I (p<0.001) 
-mean time to first 
analgesic in group I 
was 193.6 min, 
group II was 333.6 
min 
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Appendix J 
Kim, J.E., Kim, N.Y., Lee, H.S., & Kil, H.K. (2013). Effects of intrathecal 
 dexmedetomdine on  low-dose bupivacaine spinal anesthesia in elderly patients 
 undergoing transurethral prostatectomy. The Pharmaceutical Society of Japan, 
 36(6), 959-965. 
  Yes Can’t 
Tell 
No 
1 Did the trial address a clearly focused issue?  Evaluate 
adjuvant effects of intrathecal dexmedetomidine in elderly 
patients undergoing TURP surgery with low-dose 
bupivacaine spinal anesthesia. Patients divided into two 
groups:  a group that received 3mcg of dexmedetomidine 
combined with 6mg of hyperbaric bupivacaine, and 
another group that received the same amount of NS and 
bupivacaine. 
ü    
2 Was the assignment of patients to treatments 
randomized? 54 elderly patients undergoing TURP 
included in the study and placed into one of two groups by 
random number sequence. 
ü    
3 Were all the patients who entered the trial properly 
accounted for at its conclusion?  Yes, no patients 
dropped out. 
ü    
4 Were patients, health workers and study personnel 
‘blind’ to treatment?  An independent investigator 
prepared the drug solutions that were coded and provided 
to anesthetic administrator. Anesthetic administrator, 
patients, outcome assessors, and data analysts blinded to 
the allocation. 
ü    
5 Were the groups similar at the start of the trial?  
Patients were undergoing the same surgery with the same 
anesthetic technique. 39/54 participants had more than one 
systemic disease such as hypertension (24), diabetes (13), 
coronary disease (8), cerebrovascular accident (5), 
arrhythmia (3), liver cirrhosis (3), COPD (3), and chronic 
renal failure (2).  No ASA status listed, no gender 
differentiation, and no ages stated. 
 ü   
6 Aside from the experimental intervention, were the 
groups treated equally?  Each patient followed for one 
month after the procedure to assess for possible neurologic 
ü    
54 
 
effects.  An independent coordinator interviewed all 
patients a week after discharge.  At one month, coordinator 
interviewed each patient.  Patient’s assessed for new 
unusual sensations on the back, buttock, or legs. 
7 How large was the treatment effect?  The 
dexmedetomidine group showed a lower postoperative 
analgesic requirement compared to the saline group 
(p<0.01).  Analysis of time to first request of analgesic 
medication showed a significant difference between the 
two groups (p=0.006).  In the dexmedetomidine group 
postoperative analgesic request was significantly lower at 
the 7-day follow up (p<0.01). 
ü    
8 How precise was the estimate of the treatment effect?  
Study calculated that a sample size of 23 patients per group 
would be required for a power level of 80% and a 
significance level of 0.05. 
ü    
9 Can the results be applied in your context? (or to the 
local population?)   Study’s findings were appropriate for 
this systematic review. 
ü    
10 Were all clinically important outcomes considered?  
Postoperative analgesia levels recorded in both groups at 
multiple time intervals. Time to first analgesic request was 
recorded for each participant. 
ü    
11 Are the benefits worth the harms and costs?  No 
adverse outcomes were noted; the benefits outweigh the 
risks. 
ü    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
Appendix K 
 
Abdelhamid SA, El-lakany MH (2013) Intrathecal dexmedetomidine: Useful or not? J 
 Anesth  Clin Res 4:351. 
  Yes Can’t 
tell 
No 
1 Did the trial address a clearly focused issue? Purpose 
was to evaluate effects of adding dexmedetomidine to 
hyperbaric bupivacaine intrathecally. End-points were 
block characteristics among studied groups, analgesic 
needs, and intra-operative assessment of blood pressure 
and heart rate. 
ü    
2 Was the assignment of patients to treatments 
randomized? Patients were randomly divided using 
sealed envelope technique. 
ü    
3 Were all the patients who entered the trial properly 
accounted for at its conclusion? All 62 patients finished 
study. 
ü    
4 Were patients, health workers and study personnel 
‘blind’ to treatment? This was a double blinded 
randomized control trial. Medications were prepared by a 
third party. 
ü    
5 Were the groups similar at the start of the trial? 
Patients were excluded if they had any major illnesses. 
They were all ASA 1 or 2 status. Weights were similar, 
between 65-68 kilograms. The only characteristic that 
varied significantly was age, which ranged from 22-56. 
 ü   
6 Aside from the experimental intervention, were the 
groups treated equally? Each group was monitored 
throughout procedure for adverse events. Postoperatively 
they were monitored for complications including nausea, 
vomiting, shivering, bradycardia, and hypotension. 
ü    
7 How large was the treatment effect? Time to first 
required analgesic medication in intervention group 
obtained a p value of <0.0001. Total analgesic 
consumption for intervention group obtained a p value of 
<0.0001. 
ü    
8 How precise was the estimate of the treatment effect? 
Significance of the results was at the 5% level of 
significance. For the intervention group, time to first 
analgesic request had a significance level of Z=6.81 and 
total analgesic consumption has a significance level of 
Z=6.818 
ü    
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9 Can the results be applied in your context? (or to the 
local population?)  Findings were appropriate for this 
systematic review. 
ü    
10 Were all clinically important outcomes considered? 
Immediate outcomes were considered and evaluated, but 
nothing beyond immediate post-operative period was 
assessed. There was no documented follow-up with any 
participants. 
  ü  
11 Are the benefits worth the harms and costs? Although 
there were positive analgesia results in both groups, there 
were also complications noted. No financial information 
noted so it is difficult to determine if the benefit of 
improved postoperative analgesia outweighed the risk of 
harm and cost. 
 ü   
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Appendix L 
Bi, Y.-H., Cui, X.-G., Zhang, R.-Q., Song, C.-Y., & Zhang, Y.-Z. (2017). Low dose of 
 dexmedetomidine as an adjuvant to bupivacaine in cesarean surgery provides 
 better intraoperative somato-visceral sensory block characteristics and 
 postoperative analgesia. Oncotarget, 8(38), 63587–63595.   
 
  Yes Can’t 
tell 
No 
1 Did the trial address a clearly focused issue? Investigate 
the beneficial effects of dexmedetomidine on postoperative 
analgesia when combined with intrathecal bupivacaine. 
Spinal anesthesia is commonly used for c-sections, but 
there remains a lack of long-lasting postoperative 
analgesia. 
ü    
2 Was the assignment of patients to treatments 
randomized? A computer-generated randomization table 
was used to divide the participants into groups. 
ü    
3 Were all the patients who entered the trial properly 
accounted for at its conclusion? If spinal anesthesia 
failed, participants would be excluded, but the study does 
not identify how many participants were excluded; they 
did not specify how many participants finished the study. 
 ü   
4 Were patients, health workers and study personnel 
‘blind’ to treatment? Medication prescriptions were kept 
in a sealed envelope, and medication was prepared by a 
registered anesthetic nurse who was not involved in the 
study. All employees contributing to study were blinded. 
ü    
5 Were the groups similar at the start of the trial? 
Demographic profiles of participants were similar 
regarding age, weight, height, gestation age, and mean 
duration of surgery. 
 
ü  
  
6 Aside from the experimental intervention, were the 
groups treated equally? Following procedure, all 
participants were advised to avoid breastfeeding for 24 
hours; there are no published studies on the safety of 
breastfeeding after spinal dexmedetomidine. Side 
effects/complications were treated equally in each 
participant. 
 
 
ü  
  
7 How large was the treatment effect?  VAS at 6 hours 
was higher in Bup Group than the other two groups 
(P=0.0032). 
No difference was observed at 12 hours (P=0.3533). 
ü    
8 How precise was the estimate of the treatment effect? 
P-value less than 0.05 was considered statistically 
significant. 
ü    
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9 Can the results be applied in your context? (or to the 
local population?) Findings were appropriate for this 
systematic review. 
ü    
10 Were all clinically important outcomes considered? 
Along with postoperative analgesia, other outcomes 
assessed include fetal well-being, spinal block 
characteristics, side effects, and maternal stress response. 
 
ü  
  
11 Are the benefits worth the harms and costs? There were 
clear benefits on postoperative analgesia and no harm 
towards the fetus or mother. Cost analysis was not 
evaluated. 
 ü   
 
  
59 
 
Appendix M 
Patro, S.S., Deshmukh, H., Ramani, Y.R., & Das, G. (2016). Evaluation of 
 dexmedetomidine as  an adjuvant to intrathecal bupivacaine in infraumbilical 
 surgeries. Journal of Clinical and Diagnostic Research, 10(3), 13-16. 
  Yes Can’t 
tell 
No 
1 Did the trial address a clearly focused issue? Evaluate 
efficacy of intrathecal dexmedetomidine as an adjuvant to 
bupivacaine in spinal anesthesia in patients undergoing 
infraumbilical surgery. Patients divided into two groups: 
group I received hyperbaric bupivacaine with normal 
saline, group II received hyperbaric bupivacaine with 
dexmedetomidine. 
ü    
2 Was the assignment of patients to treatments 
randomized? Patients were randomly allocated into two 
groups using sealed envelope technique. 
ü    
3 Were all the patients who entered the trial properly 
accounted for at its conclusion? Yes, no patients dropped 
out. 
ü    
4 Were patients, health workers and study personnel 
‘blind’ to treatment? Medication was prepared by an 
anesthesiologist not included in study. Double blind study. 
 
ü  
  
5 Were the groups similar at the start of the trial? 
Demographics were comparable with respect to age, sex, 
weight, height, duration, and type of surgery. 
ü    
6 Aside from the experimental intervention, were the 
groups treated equally? All participants were treated 
equally regarding side effects/adverse events. 
ü    
7 How large was the treatment effect? Postoperative VAS 
ratings were significantly different at 6 hours between the 
two groups, p<0.001. 
ü    
8 How precise was the estimate of the treatment effect?  
P value <0.05 was considered significant. 
ü    
9 Can the results be applied in your context? (or to the 
local population?)  Findings were appropriate for this 
systematic review. 
ü    
10 Were all clinically important outcomes considered? 
Time to first analgesic request was recorded; VAS ratings 
were recorded at 3 hours, 6 hours, and 12 hours postop. 
ü    
11 Are the benefits worth the harms and costs? Benefits of 
dexmedetomidine on postoperative analgesia were clear; 
cost analysis was not performed. 
 ü   
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Appendix N 
Salem, R.A., Darweesh, E.I., Wanis, M.A., & Mohamed, A.A. (2015). Evaluation of the 
 effects  of intrathecal bupivacaine-dexmedetomidine for lumbar spine fusion: a 
 double blinded randomized controlled study. European Review for Medical and 
 Pharmacological Sciences, 19, 4542-4548. 
 
  Yes Can’t 
tell 
No 
1 Did the trial address a clearly focused issue? Evaluate 
efficacy of intrathecal dexmedetomidine at improving 
postoperative analgesia during spinal surgery. 
ü   
2 Was the assignment of patients to treatments 
randomized? Randomization and enrollment were 
performed using sequentially numbered closed envelopes. 
ü   
3 Were all the patients who entered the trial properly 
accounted for at its conclusion? 52 participants were 
present at the start, and 52 participants at the conclusion 
ü   
4 Were patients, health workers and study personnel 
‘blind’ to treatment? This was a double blinded study. 
One anesthesiologist performed the spinal blocks while 
another followed the patients postoperatively. Both 
anesthesiologists were blinded to group allocation. 
ü   
5 Were the groups similar at the start of the trial? Patient 
demographic data did not differ between the two study 
groups 
ü   
6 Aside from the experimental intervention, were the 
groups treated equally? No other information was 
provided on group treatment. 
 ü   
7 How large was the treatment effect? Time to first 
analgesic request was significantly longer in group D 
(p<0.0001). Total dose of total analgesic medication over 
24 hours was smaller in group D (p<0.0001) 
ü   
8 How precise was the estimate of the treatment effect? 
Level of statistical significance was considered at p<0.05 
ü   
9 Can the results be applied in your context? (or to the 
local population?)  Findings were appropriate for this 
systematic review. 
ü   
10 Were all clinically important outcomes considered? 
Time to first analgesic request was recorded, as well as total 
dose of analgesic medications. 
ü   
11 Are the benefits worth the harms and costs?  No adverse 
outcomes were noted in the intervention group; benefits 
outweigh the risks. Cost analysis was not done. 
ü   
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Appendix O 
Yektaş, A., & Belli, E. (2014). The effects of 2 μg and 4 μg doses of dexmedetomidine in 
 combination with intrathecal hyperbaric bupivacaine on spinal anesthesia and its 
 postoperative analgesic characteristics. Pain Research & Management : The 
 Journal of the Canadian Pain 
  Yes Can’t 
tell 
No 
1 Did the trial address a clearly focused issue? Evaluated 
different doses of intrathecal dexmedetomidine and 
whether they had effects on properties of hyperbaric 
bupivacaine. Goal was to prolong postoperative analgesia 
while providing quality anesthesia. 
ü   
2 Was the assignment of patients to treatments 
randomized? Patients were randomly divided into three 
groups. 
ü   
3 Were all the patients who entered the trial properly 
accounted for at its conclusion? 60 male patients 
participated and were present at conclusion of study. 
ü   
4 Were patients, health workers and study personnel 
‘blind’ to treatment?  Double-blind study. 
ü   
5 Were the groups similar at the start of the trial? Ages 
were between 20-30, all ASA status 1. Mean weight 
among participants in group 1, 2, and 3 were 72 kg, 72 kg, 
and 73 kg respectively. Mean height among participants in 
group 1, 2, and 3 were 174 cm, 173 cm, and 172 cm 
respectively. 
ü   
6 Aside from the experimental intervention, were the 
groups treated equally? Each participant was monitored 
throughout procedure in the same manner. Surgery 
duration was 20 minutes for each participant. Side effects 
were treated symptomatically with the same interventions. 
ü   
7 How large was the treatment effect? Time to pain onset 
obtained a P value of <0.001. Amount of analgesic 
medication consumption over 24 hours obtained a P value 
of <0.001. 
ü   
8 How precise was the estimate of the treatment effect? P 
< 0.05 was considered statistically significant. 
ü   
9 Can the results be applied in your context? (or to the 
local population?)  Findings were appropriate for this 
systematic review. 
ü   
10 Were all clinically important outcomes considered? 
Analgesic requirements, side effects, and complications 
were all considered. 
ü   
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11 Are the benefits worth the harms and costs? This study 
found clear benefits of using dexmedetomidine with 
hyperbaric bupivacaine intrathecally with no additional 
harm to the patient, but cost analysis was not evaluated. 
 ü   
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Appendix P 
Authors  Procedure/Type 
of surgery 
Pain Scale 
Used 
Dosage 
Used 
(mcg) 
Control 
Group-
mean time 
to first 
analgesic 
request 
(minutes) 
Intervention 
Group- mean 
time to first 
analgesic 
request 
(minutes) 
Kim et al., 
2013 
Transurethral 
prostatectomy 
VAS 3 mcg 345 1360 
Abdelhamid 
& El-lakany, 
2013 
Lower 
abdominal 
surgery 
No scale; 
results 
were 
assessed 
by 
evaluating 
time to 
analgesic 
request 
5 mcg 259 381 
Yektaş, A., & 
Belli, E., 
2014 
Inguinal surgery Numerical 
pain rating 
scale 
2 mcg 
&  
4 mcg 
220 -group 2: 371 
-group 3: 
1042 
Bi et al., 
2017 
Cesarian section VAS 3 mcg 
& 
5mcg 
 
1320 -Bup+Dex3 
Group: 1488 
-Bup+Dex5 
Group: 1428 
Salem, R.A. 
et al., 2015 
Posterolateral 
lumbar spine 
fusion 
No scale; 
results 
were 
assessed 
by 
evaluating  
time to 
analgesic 
request 
 
 
 
 
 
 
reaurest 
 
 
 
time to 
analgesic 
request 
5 mcg 269 399 
Patro et al., 
2016 
Infra-umbilical 
surgeries 
VAS 5 mcg 193.6 333.6 
 
